{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":598,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":598,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"88f7942411f9","filters":{"venue":"Blood Advances"}},"results":[{"id":"W3090209681","doi":"10.1182/bloodadvances.2020001830","title":"American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1428,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Impact; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Pulmonary embolism; Guideline; Deep vein; Thrombosis; Warfarin; Venous thromboembolism; Venous thrombosis; Intensive care medicine; Hematology; Vitamin K antagonist; Internal medicine; Atrial fibrillation","retraction":null,"screen_n_in":null,"score":{"opus":0.05663031161282125,"gpt":0.3469072988106524,"spread":0.2902769871978311,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008752998,0.0002779327,0.001800151,0.00005100163,0.00005085573,0.000005005049,0.0001407038,0.00005776008,0.00002428244],"category_scores_gemma":[0.00002221397,0.0002307457,0.0003211526,0.0002942611,0.0003540617,0.0000822603,0.00009996381,0.00003942853,8.684972e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001620973,"about_ca_system_score_gemma":0.00002993595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007615179,"about_ca_topic_score_gemma":0.000005826524,"domain_scores_codex":[0.9981991,0.00002537348,0.0007784,0.0004411894,0.0002638833,0.0002920321],"domain_scores_gemma":[0.9986795,0.00009029742,0.0005377381,0.0003037146,0.0002551601,0.0001335485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001652457,0.03746694,0.05332445,0.04371351,0.02436109,0.0001301532,0.0141445,0.001247226,0.05774392,0.03762065,0.008812299,0.7197828],"study_design_scores_gemma":[0.02913166,0.0642807,0.383942,0.003184141,0.02919003,0.0001318078,0.05691627,0.008227758,0.252862,0.004123469,0.1655464,0.002463726],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9553055,0.02975579,0.00163828,0.009755877,0.0001355959,0.002280649,0.000129639,0.00006730846,0.0009313659],"genre_scores_gemma":[0.8900697,0.05855081,0.05015133,0.0008085887,0.0001475215,0.0001733676,0.00003877751,0.00004185791,0.00001800251],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7173191,"threshold_uncertainty_score":0.9409538,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2993666578","doi":"10.1182/bloodadvances.2019000966","title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1336,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute; University of Oklahoma Health Sciences Center; National Institutes of Health; University of Oklahoma","keywords":"Medicine; Guideline; Rituximab; Immune thrombocytopenia; Intensive care medicine; Clinical trial; MEDLINE; Randomized controlled trial; Dosing; Hematology; Family medicine; Pediatrics; Internal medicine; Immunology; Antibody; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02765874513328463,"gpt":0.3483066406333629,"spread":0.3206478955000782,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005166215,0.0001101666,0.0006309641,0.00002035038,0.00002432779,0.000002584596,0.00006539548,0.00003238574,0.00004281004],"category_scores_gemma":[0.00002961219,0.00008075754,0.0001725893,0.00009047151,0.00008020759,0.00007032889,0.0000209732,0.00003624681,0.00002357422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005523671,"about_ca_system_score_gemma":0.00004146533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000541792,"about_ca_topic_score_gemma":0.000007731504,"domain_scores_codex":[0.9992834,0.00000578262,0.00026075,0.0001825926,0.00009413717,0.0001733243],"domain_scores_gemma":[0.9993877,0.00006203423,0.0001620464,0.0001963208,0.0001592588,0.00003260482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00161922,0.004589567,0.5560668,0.002563733,0.004486002,0.00007715941,0.0007204132,0.00009181353,0.23295,0.004258997,0.0420905,0.1504857],"study_design_scores_gemma":[0.04004636,0.008788349,0.06855801,0.0008160697,0.00183131,0.0007462912,0.003530784,0.0006449666,0.4324631,0.00429938,0.4372657,0.001009604],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828431,0.01364961,0.0001260327,0.001859951,0.0001114353,0.0005654613,0.00003592378,0.0000280934,0.0007803956],"genre_scores_gemma":[0.9419718,0.003381838,0.05112065,0.0008897127,0.00005212348,0.00004073414,0.00008790907,0.00002558313,0.002429589],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4875088,"threshold_uncertainty_score":0.3293197,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211106014","doi":"10.1182/bloodadvances.2019000812","title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1090,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Amgen","keywords":"Immune thrombocytopenia; Consensus conference; Medicine; Intensive care medicine; MEDLINE; Pregnancy; Expectant management; Immunology; Political science; Internal medicine; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.01391461229368556,"gpt":0.2590732018037222,"spread":0.2451585895100367,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006887885,0.00006166017,0.0001625959,0.00002324435,0.00002042322,0.000005175127,0.00003694671,0.00001569966,0.00004880274],"category_scores_gemma":[0.000007163453,0.00003819344,0.00001972496,0.00004766795,0.00005296694,0.00003626204,0.00002553115,0.00003617092,0.00001082217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008882479,"about_ca_system_score_gemma":0.00001301505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008152096,"about_ca_topic_score_gemma":0.000001374949,"domain_scores_codex":[0.9995179,0.000009262986,0.0001501996,0.0001248109,0.0001412526,0.00005658645],"domain_scores_gemma":[0.9996799,0.00002617857,0.0001034669,0.0001441675,0.00002884278,0.00001741674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001288992,0.001857416,0.862457,0.0008803125,0.004487055,0.004671379,0.0004398778,0.00006150825,0.06109925,0.02401719,0.001689788,0.03705027],"study_design_scores_gemma":[0.006310723,0.0004869014,0.9344418,0.0005224382,0.0003748354,0.0007351429,0.0003531599,0.00004198351,0.03753687,0.002569162,0.01647318,0.0001537831],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9711279,0.0008134769,7.696478e-7,0.001707425,0.00009692189,0.0003429905,0.000005155084,0.00001162241,0.0258937],"genre_scores_gemma":[0.9967604,0.0006484156,0.0008541103,0.0002012852,0.000007387008,0.000008745829,0.00009298066,0.000005023278,0.00142161],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07198485,"threshold_uncertainty_score":0.1557483,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3127460195","doi":"10.1182/bloodadvances.2020003442","title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":849,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Impact; Provincial Health Services Authority; University of Toronto; St. Michael's Hospital; University of British Columbia; Ottawa Hospital; University of Ottawa","funders":"Marie Curie","keywords":"Medicine; Guideline; Intensive care medicine; Cancer; Venous thromboembolism; Fondaparinux; Ambulatory; Low molecular weight heparin; Hematology; Internal medicine; Heparin; Thrombosis; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02594429341600926,"gpt":0.3358472331441514,"spread":0.3099029397281421,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005415011,0.0001258417,0.0007076663,0.00003757149,0.0000240237,0.000003028774,0.00003341306,0.00002231137,0.00002117063],"category_scores_gemma":[0.000006701235,0.00009627704,0.00008154803,0.000176199,0.00008936547,0.00005229968,0.00003405668,0.00002147414,1.349364e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002683858,"about_ca_system_score_gemma":0.00005243303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001367433,"about_ca_topic_score_gemma":0.0002669606,"domain_scores_codex":[0.9991009,0.00001583197,0.0003237341,0.0002540633,0.0001440468,0.0001614275],"domain_scores_gemma":[0.9993176,0.00002439364,0.0002114861,0.000167176,0.0002458638,0.00003350529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0003054681,0.01447356,0.4456835,0.002932574,0.003279826,0.00002096783,0.0008846547,0.0002732282,0.0003281188,0.00218369,0.0007072634,0.5289271],"study_design_scores_gemma":[0.01085238,0.004875297,0.9531228,0.001577222,0.00205895,0.00000370988,0.003072143,0.00004069565,0.013475,0.0003747049,0.01033626,0.0002108578],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904004,0.00755786,0.0001594586,0.0007047111,0.0000539398,0.0009214975,0.00003012781,0.000006423514,0.0001656271],"genre_scores_gemma":[0.9124394,0.03602838,0.0504231,0.0002441337,0.00005202624,0.0004674853,0.00007990575,0.00002626807,0.0002392933],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5287163,"threshold_uncertainty_score":0.3926064,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2902174064","doi":"10.1182/bloodadvances.2018022954","title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":812,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McGill University; Impact","funders":"","keywords":"Venous thromboembolism; Medicine; Hematology; Intensive care medicine; Internal medicine; Disease; Emergency medicine; Thrombosis","retraction":null,"screen_n_in":null,"score":{"opus":0.02535771443580039,"gpt":0.343428618960238,"spread":0.3180709045244376,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003375018,0.0002284311,0.001256082,0.0000661422,0.0001069592,0.000006366118,0.0001759449,0.00008576416,0.00002750203],"category_scores_gemma":[0.000204705,0.0001817697,0.0002447486,0.0001834336,0.000751893,0.00008216233,0.000125732,0.00005098753,9.79313e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001384786,"about_ca_system_score_gemma":0.00004831517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004853629,"about_ca_topic_score_gemma":0.00000910346,"domain_scores_codex":[0.9980587,0.00002213096,0.0007238011,0.0004246694,0.0004210547,0.0003496693],"domain_scores_gemma":[0.9981797,0.0001056238,0.0004712567,0.0003129891,0.0008026273,0.0001277892],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003034384,0.03494144,0.112697,0.04007529,0.01419237,0.00002068361,0.004817332,0.000006114279,0.002097985,0.03362578,0.08815244,0.6663392],"study_design_scores_gemma":[0.0775587,0.1130445,0.4289182,0.005972836,0.009764494,0.00003776844,0.007551731,0.0009711586,0.04858311,0.01295014,0.2924312,0.002216236],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866745,0.003082205,0.004373074,0.0015224,0.0004018644,0.003420182,0.00009765791,0.00004889767,0.0003791817],"genre_scores_gemma":[0.8422707,0.00672968,0.1487476,0.00107662,0.000273158,0.0006611121,0.00009186947,0.00005692829,0.00009231778],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.664123,"threshold_uncertainty_score":0.7412353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2902914300","doi":"10.1182/bloodadvances.2018024489","title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":719,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Impact; McMaster University","funders":"National Heart, Lung, and Blood Institute","keywords":"Venous thromboembolism; Medicine; Hematology; Heparin-induced thrombocytopenia; Heparin; MEDLINE; Intensive care medicine; Internal medicine; Political science; Thrombosis; Law","retraction":null,"screen_n_in":null,"score":{"opus":0.09715893215794777,"gpt":0.391221271717073,"spread":0.2940623395591253,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003611316,0.0004127707,0.002168847,0.0001194758,0.0001670558,0.00001199953,0.0004138655,0.0001520331,0.00008850478],"category_scores_gemma":[0.00007975552,0.0003564473,0.0004730645,0.0005908362,0.0008572716,0.0002113648,0.0002124421,0.0001470827,0.00002477995],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000438808,"about_ca_system_score_gemma":0.0001683181,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002103149,"about_ca_topic_score_gemma":0.00007408448,"domain_scores_codex":[0.9970689,0.00004710701,0.001147186,0.0006822192,0.0004156923,0.0006388748],"domain_scores_gemma":[0.9971215,0.0001274927,0.000723816,0.000859282,0.0009821916,0.0001857094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001212747,0.006964521,0.02850589,0.006938125,0.009647369,0.00003887594,0.002369572,0.00000931558,0.7905955,0.02850982,0.01202804,0.1131802],"study_design_scores_gemma":[0.006080926,0.006889103,0.05525279,0.001001882,0.002511095,0.0001425346,0.002547365,0.000126477,0.8909296,0.002293286,0.03153203,0.0006929086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892647,0.00117578,0.0008344632,0.001389491,0.0005049793,0.00144973,0.0000559298,0.0001078219,0.005217094],"genre_scores_gemma":[0.908608,0.001555801,0.08847484,0.0006155684,0.000354733,0.0001081176,0.00002806981,0.00006724911,0.0001876774],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1124873,"threshold_uncertainty_score":0.9998888,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2903022860","doi":"10.1182/bloodadvances.2018024802","title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":596,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Thrombosis and Atherosclerosis Research Institute; University of Ottawa; McMaster University; Impact; Ottawa Hospital","funders":"","keywords":"Venous thromboembolism; Hematology; Medicine; Context (archaeology); Pregnancy; Intensive care medicine; Internal medicine; Venous thrombosis; Cardiology; Thrombosis; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.06259893554747141,"gpt":0.3585261105300209,"spread":0.2959271749825494,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003010482,0.000202073,0.001208916,0.00008013169,0.00006056501,0.000003665428,0.0002862745,0.00007715604,0.0000242859],"category_scores_gemma":[0.00004625603,0.0001470685,0.0002347905,0.0003938325,0.0006330024,0.00008498049,0.00006061293,0.00008083481,0.000002151404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001015241,"about_ca_system_score_gemma":0.00006254873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008651668,"about_ca_topic_score_gemma":0.00005725707,"domain_scores_codex":[0.9981808,0.0000566063,0.0008343084,0.0002986055,0.0003399778,0.0002896771],"domain_scores_gemma":[0.998164,0.0001235345,0.0006530372,0.0005014846,0.0005161755,0.00004175471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009721632,0.02898022,0.01095018,0.01570034,0.006857325,0.00003658823,0.03587014,0.00005112824,0.1112287,0.3367119,0.008149695,0.4444916],"study_design_scores_gemma":[0.01833789,0.01983452,0.08038458,0.008412833,0.004322818,0.0001766619,0.06195217,0.0005391058,0.7544628,0.03187197,0.0187232,0.0009814488],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.966951,0.01932692,0.003798463,0.003119036,0.0006830827,0.003246341,0.000118414,0.00006888001,0.002687866],"genre_scores_gemma":[0.9700751,0.002112085,0.02675763,0.000780815,0.0001110777,0.00008542903,0.00001499558,0.00002572877,0.00003708799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6432341,"threshold_uncertainty_score":0.599728,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2991907358","doi":"10.1182/bloodadvances.2019000975","title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":594,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McGill University; Impact; Dalhousie University","funders":"","keywords":"Medicine; Guideline; Perioperative; Venous thromboembolism; Prostatectomy; Vascular surgery; Low molecular weight heparin; Orthopedic surgery; Surgery; Cardiac surgery; Intensive care medicine; Heparin; Internal medicine; Thrombosis; Prostate","retraction":null,"screen_n_in":null,"score":{"opus":0.02140337767280229,"gpt":0.3350250171940012,"spread":0.3136216395211989,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003654622,0.0002979272,0.002398442,0.0001652665,0.00003199149,0.000004721053,0.000257451,0.000105454,0.00005136008],"category_scores_gemma":[0.00003337425,0.0002655886,0.0004724186,0.0004183048,0.0002401968,0.0001520859,0.0001494039,0.00009807908,0.000004661535],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003602708,"about_ca_system_score_gemma":0.00006439053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001863447,"about_ca_topic_score_gemma":0.00001452001,"domain_scores_codex":[0.9972241,0.0000579338,0.001280107,0.0004972251,0.0005021145,0.0004385055],"domain_scores_gemma":[0.9978194,0.0001007973,0.0009836778,0.0005202153,0.000502386,0.00007347529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002700327,0.1284769,0.4245833,0.04783708,0.01294444,0.00007884626,0.006013544,0.001957171,0.005492918,0.05107484,0.0129671,0.3058736],"study_design_scores_gemma":[0.02427668,0.01447593,0.9104301,0.004017815,0.002809163,0.00001761413,0.003246354,0.0001907526,0.01773144,0.004198526,0.01778739,0.0008182226],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913694,0.003968502,0.0001112965,0.0002645822,0.0003384494,0.002696855,0.00006792913,0.00002990356,0.001153099],"genre_scores_gemma":[0.9760672,0.008346518,0.01492526,0.0001285802,0.00005945168,0.0001483829,0.0001203247,0.00004820238,0.0001561199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4858468,"threshold_uncertainty_score":0.9999796,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3121114429","doi":"10.1182/bloodadvances.2020003265","title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":542,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Guideline; Von Willebrand disease; Grading (engineering); Multidisciplinary approach; MEDLINE; Family medicine; Intensive care medicine; Disease; Von Willebrand factor; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02462713352040196,"gpt":0.3049519138868048,"spread":0.2803247803664028,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005190269,0.0001259734,0.0002585328,0.00002498476,0.00006716554,0.00001038036,0.00005989614,0.0000248797,0.0004187363],"category_scores_gemma":[0.0004215882,0.00007478421,0.0001120174,0.0001559392,0.000051576,0.00006155661,0.00002577947,0.00005740904,0.00002327423],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005821184,"about_ca_system_score_gemma":0.00007104069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000100031,"about_ca_topic_score_gemma":0.00002894707,"domain_scores_codex":[0.999174,0.00002657006,0.0002076062,0.0002169438,0.0002301048,0.0001447473],"domain_scores_gemma":[0.9992702,0.0001383313,0.00007284773,0.0002892269,0.0001380452,0.0000913483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005979324,0.005111002,0.8373317,0.0003510713,0.001007621,0.003801652,0.0002027741,0.0001156566,0.001080042,0.001769476,0.01985872,0.1287723],"study_design_scores_gemma":[0.01294671,0.001167197,0.133465,0.002287071,0.002564868,0.0001227061,0.001123618,0.00009270463,0.1419559,0.007904586,0.6957208,0.0006487963],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.948293,0.03816948,0.000004415242,0.009900169,0.0001393556,0.0001999442,0.00007069068,0.00001377225,0.003209204],"genre_scores_gemma":[0.9786755,0.01687161,0.0005089827,0.001549125,0.0001385686,0.00007360688,0.00006894884,0.00001656692,0.002097076],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7038667,"threshold_uncertainty_score":0.4584869,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2902233584","doi":"10.1182/bloodadvances.2018024893","title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":507,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; McMaster University; Impact","funders":"","keywords":"Venous thromboembolism; Hematology; Medicine; Intensive care medicine; Internal medicine; Thrombosis","retraction":null,"screen_n_in":null,"score":{"opus":0.05807273748209407,"gpt":0.3708015378970465,"spread":0.3127288004149524,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002647174,0.0002098685,0.001075668,0.00009031883,0.00006287204,0.000004198864,0.0001923872,0.00004622855,0.00003767631],"category_scores_gemma":[0.000006700834,0.0001776801,0.0002619942,0.0002994535,0.000489146,0.00009204698,0.00009942219,0.0000359622,0.000002028371],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001410334,"about_ca_system_score_gemma":0.00001959475,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000472953,"about_ca_topic_score_gemma":0.000004188277,"domain_scores_codex":[0.998229,0.00002015766,0.0007710817,0.000343464,0.0003424305,0.000293811],"domain_scores_gemma":[0.9983341,0.00003914577,0.0006413261,0.0004446958,0.0004906959,0.00005008923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00188271,0.02472911,0.01694942,0.02321692,0.02350804,0.0000363218,0.003506719,0.001322759,0.02713406,0.1041732,0.03483677,0.738704],"study_design_scores_gemma":[0.02029395,0.02148451,0.3233966,0.004968546,0.007613289,0.00003933761,0.01710844,0.001928739,0.4847655,0.004395383,0.1127879,0.001217788],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9748797,0.007252252,0.01169988,0.001171624,0.0003446111,0.002273255,0.00003262907,0.00005636322,0.002289641],"genre_scores_gemma":[0.7709092,0.01934105,0.2090201,0.000318127,0.000138239,0.0001007127,0.00002442244,0.00003243806,0.0001157029],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7374862,"threshold_uncertainty_score":0.7245584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2902418274","doi":"10.1182/bloodadvances.2018024786","title":"American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":445,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster Children's Hospital; Hospital for Sick Children; SickKids Foundation; University of Toronto; Impact","funders":"","keywords":"Medicine; Guideline; Asymptomatic; Intensive care medicine; Psychological intervention; Venous thrombosis; Deep vein; Thrombosis; Appropriate Use Criteria; Antithrombotic; Multidisciplinary approach; Internal medicine; Nursing; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.07240966129061698,"gpt":0.3675710435781027,"spread":0.2951613822874857,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001432693,0.0002658482,0.001546971,0.0001194513,0.00007643409,0.000003723561,0.0001594757,0.00008974365,0.0000450805],"category_scores_gemma":[0.0000213712,0.0002188232,0.0003650128,0.0004157356,0.000409465,0.00007562302,0.0000473746,0.00003808733,0.000004497916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002337199,"about_ca_system_score_gemma":0.00009100256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005991988,"about_ca_topic_score_gemma":0.00001043544,"domain_scores_codex":[0.9980868,0.0000297532,0.0008552334,0.0003748402,0.0003267192,0.0003266349],"domain_scores_gemma":[0.9978909,0.00007998171,0.0007828445,0.0004864048,0.0006689443,0.00009093543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00246796,0.09530463,0.04174544,0.0225298,0.02741476,0.00005539824,0.01571769,0.0002191913,0.1966338,0.1536873,0.0138155,0.4304085],"study_design_scores_gemma":[0.01744163,0.04501753,0.05661204,0.0006749026,0.01288089,0.0001104461,0.006042782,0.0004170983,0.8282754,0.00942775,0.02216675,0.0009328145],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838711,0.009613384,0.002962194,0.0005755926,0.0005288413,0.001428044,0.0001103996,0.00007667463,0.0008337431],"genre_scores_gemma":[0.9005695,0.007042343,0.09139627,0.000208595,0.0005289515,0.00007883966,0.00003077302,0.00004317152,0.0001015822],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6316416,"threshold_uncertainty_score":0.8923351,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3036739471","doi":"10.1182/bloodadvances.2020001851","title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":432,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Psychological intervention; Chronic pain; Intensive care medicine; Clinical trial; Guideline; Multidisciplinary approach; MEDLINE; Disease; Intervention (counseling); Health care; Randomized controlled trial; Physical therapy; Nursing; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01390190721058878,"gpt":0.2912497343093321,"spread":0.2773478270987433,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007269336,0.00009571141,0.0003161333,0.000009579595,0.00002355015,0.000001514036,0.00005285871,0.00002492873,0.00001042983],"category_scores_gemma":[0.00001968332,0.00007416563,0.0001139871,0.0001335654,0.0001719424,0.00002709432,0.00003773525,0.00004284823,5.232171e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000004064654,"about_ca_system_score_gemma":0.00003732731,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002563235,"about_ca_topic_score_gemma":5.526085e-7,"domain_scores_codex":[0.9993075,0.00001395959,0.000263012,0.0001827546,0.00009509341,0.0001377022],"domain_scores_gemma":[0.9995366,0.00003678352,0.0001436968,0.00009891676,0.0000785584,0.0001054286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0035519,0.003443696,0.06691236,0.09610045,0.009909194,0.0003420764,0.002799457,0.001809105,0.1099741,0.004110437,0.1686746,0.5323726],"study_design_scores_gemma":[0.02896673,0.01151203,0.003539135,0.002416829,0.01130415,0.00004195469,0.01944633,0.03327238,0.1460008,0.001370819,0.7409113,0.00121759],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6318681,0.2691732,0.01274283,0.08233172,0.0001637447,0.002437493,0.0002643986,0.0001348385,0.0008836993],"genre_scores_gemma":[0.860176,0.08416764,0.05115581,0.003801813,0.0001613292,0.00006650048,0.00006466616,0.0000369603,0.00036929],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5722367,"threshold_uncertainty_score":0.3024386,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3128604271","doi":"10.1182/bloodadvances.2020003763","title":"American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":416,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph’s Healthcare Hamilton; Ottawa Hospital; University of Ottawa; McGill University; Impact; McMaster University; University of Toronto; Cochrane; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Guideline; Intensive care medicine; MEDLINE; Grading (engineering); Evidence-based medicine; Randomized controlled trial; Clinical trial; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease; Alternative medicine; Infectious disease (medical specialty); Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.07209585009790037,"gpt":0.338944024403058,"spread":0.2668481743051576,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009015961,0.00008918012,0.0004389619,0.00003385184,0.00003356503,0.000004271533,0.00004577544,0.000021087,0.00002600435],"category_scores_gemma":[0.0003816219,0.00005511956,0.00007737095,0.0002581217,0.0001350572,0.00005743212,0.00002615064,0.00003701337,3.276267e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001403428,"about_ca_system_score_gemma":0.00008004306,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009715834,"about_ca_topic_score_gemma":0.00009640554,"domain_scores_codex":[0.9991781,0.00002852218,0.0002980636,0.0001867603,0.0001891831,0.0001193771],"domain_scores_gemma":[0.998984,0.0002446858,0.0002250785,0.0002327886,0.0002811258,0.00003235933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003392118,0.004667788,0.9577299,0.001209208,0.0005398486,0.000006163066,0.000691719,0.002924376,0.001198126,0.007096343,0.004939206,0.0186581],"study_design_scores_gemma":[0.006064299,0.003840015,0.9171105,0.0005641927,0.0004610127,0.000002729383,0.001748918,0.0003923536,0.02679851,0.0006352311,0.04214799,0.0002342402],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938412,0.0003706077,0.000803633,0.004283611,0.00003915693,0.0006057157,0.0000246417,0.000005894106,0.000025521],"genre_scores_gemma":[0.9778153,0.0006487222,0.01899206,0.00239388,0.00002618041,0.00004588971,0.00003962434,0.00001151156,0.00002685034],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0406194,"threshold_uncertainty_score":0.224771,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3111394247","doi":"10.1182/bloodadvances.2020002827","title":"A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":413,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Cilag; National Cancer Institute; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"Multiple myeloma; Term (time); Negativity effect; Meta-analysis; Oncology; Internal medicine; Survival analysis; Medicine; Psychology; Developmental psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.04332111366551855,"gpt":0.341869319960231,"spread":0.2985482062947124,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003672391,0.0005908171,0.005840371,0.0005236221,0.00005423533,0.000034946,0.0003849214,0.0001328126,0.00009627027],"category_scores_gemma":[0.0006266502,0.0002810051,0.001458893,0.001898579,0.0001193153,0.0002478012,0.0001752049,0.0005067838,0.00000857539],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006723835,"about_ca_system_score_gemma":0.0002188728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002602705,"about_ca_topic_score_gemma":0.008955328,"domain_scores_codex":[0.9963573,0.0005841624,0.0008715783,0.0006889646,0.0009516716,0.0005463684],"domain_scores_gemma":[0.9972773,0.001159005,0.0005451494,0.0007140194,0.000123304,0.0001812908],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001345859,0.001668924,0.8151978,0.002090266,0.05345762,0.0001237919,0.00007954464,0.000001848486,5.357849e-8,0.000005526409,2.695312e-7,0.1272397],"study_design_scores_gemma":[0.00521406,0.0004367565,0.8160087,0.000681098,0.1546258,0.000002206287,0.00007253313,0.000009396179,0.000009869166,0.00001064091,0.02259347,0.0003354893],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0196265,0.9770841,0.000006609968,0.00004390997,0.0000225401,0.002373925,0.0006848276,0.00002085709,0.0001367409],"genre_scores_gemma":[0.1825961,0.8155765,0.0003386547,0.00001605615,0.00002799223,0.0006100949,0.0006759451,0.00006046132,0.00009821387],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1629696,"threshold_uncertainty_score":0.9999642,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2903137725","doi":"10.1182/bloodadvances.2018024828","title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":411,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Impact; University of Calgary; University of Ottawa; Thrombosis and Atherosclerosis Research Institute; Ottawa Hospital; Rockyview General Hospital; McMaster University","funders":"","keywords":"Venous thromboembolism; Medicine; Hematology; Internal medicine; Intensive care medicine; Thrombosis","retraction":null,"screen_n_in":null,"score":{"opus":0.0496841269740711,"gpt":0.3585703247806385,"spread":0.3088861978065675,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004215623,0.0004147863,0.002744824,0.0001785075,0.0001303721,0.000008065626,0.0004372789,0.0001224877,0.00009981197],"category_scores_gemma":[0.00009399883,0.0003660887,0.000579981,0.0005707227,0.001262134,0.0001540799,0.0002373053,0.0001043927,0.000008194845],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003428216,"about_ca_system_score_gemma":0.0000929821,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003037371,"about_ca_topic_score_gemma":0.00005023308,"domain_scores_codex":[0.9967591,0.00004667188,0.001370693,0.0006301625,0.0005687571,0.0006246816],"domain_scores_gemma":[0.9965732,0.0001983102,0.001173333,0.0008568268,0.001057115,0.0001412494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001275598,0.07021322,0.04590912,0.04385531,0.0292786,0.00009024656,0.009710061,0.0003232186,0.02168114,0.102913,0.219434,0.4553165],"study_design_scores_gemma":[0.01284942,0.02971686,0.1834331,0.006060595,0.01441761,0.0001052908,0.01659023,0.0002671897,0.5068511,0.009718661,0.2182277,0.001762195],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9676941,0.01806763,0.00203807,0.002711893,0.0009049153,0.003240632,0.0002681994,0.0001388505,0.004935697],"genre_scores_gemma":[0.8948784,0.02464257,0.078206,0.001089191,0.0004988736,0.0004325762,0.00004581093,0.00009088299,0.0001156247],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4851699,"threshold_uncertainty_score":0.9998791,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3120545968","doi":"10.1182/bloodadvances.2020003264","title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":367,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Queen's University; Impact","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Guideline; Desmopressin; Intensive care medicine; Von Willebrand disease; Multidisciplinary approach; Context (archaeology); Family medicine; Von Willebrand factor; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01904940616029946,"gpt":0.2969092868152321,"spread":0.2778598806549326,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005048699,0.0001139042,0.0002015237,0.00002078641,0.0000579241,0.000009132615,0.00005880048,0.00001643681,0.0002660357],"category_scores_gemma":[0.00003761622,0.00006826301,0.00008647158,0.0001353875,0.00003642914,0.00004650343,0.00003391075,0.00004311281,0.00002490683],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005859277,"about_ca_system_score_gemma":0.00003013531,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003104456,"about_ca_topic_score_gemma":0.000006892971,"domain_scores_codex":[0.9992222,0.000016637,0.0001868117,0.0002062496,0.0002337378,0.0001343335],"domain_scores_gemma":[0.9994575,0.0000317113,0.00006017452,0.0002933711,0.00008710903,0.00007013814],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002690469,0.01442295,0.180427,0.003301661,0.008369205,0.03119808,0.0004725214,0.0006088566,0.003040166,0.0298912,0.03078973,0.6947882],"study_design_scores_gemma":[0.01799571,0.000935964,0.08912671,0.003748529,0.004299905,0.0001323433,0.002531323,0.0001493397,0.04311966,0.01286404,0.8243974,0.0006991153],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9400705,0.03255722,0.000021607,0.008103133,0.0001808862,0.0003337854,0.00004391714,0.00001849315,0.01867049],"genre_scores_gemma":[0.9669977,0.01750961,0.002424955,0.001493091,0.0001169334,0.00005072443,0.00009188041,0.00002112626,0.01129397],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7936077,"threshold_uncertainty_score":0.2912904,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4224138250","doi":"10.1182/bloodadvances.2021006434","title":"Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia ","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Pharmacyclics","keywords":"Ibrutinib; Chlorambucil; Chronic lymphocytic leukemia; Medicine; Internal medicine; Hazard ratio; Adverse effect; Oncology; Confidence interval; Leukemia; Gastroenterology; Chemotherapy; Cyclophosphamide","retraction":null,"screen_n_in":null,"score":{"opus":0.01781755912526684,"gpt":0.2833469322780211,"spread":0.2655293731527543,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001556672,0.0004076912,0.0006515599,0.0001835913,0.0004744885,0.00003794583,0.0003522563,0.00007427937,0.0005815467],"category_scores_gemma":[0.0001943685,0.0003191308,0.0001936559,0.0005071328,0.00009692275,0.0001510541,0.0002431325,0.0001661387,0.00008124535],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.07110418,"about_ca_system_score_gemma":0.01558298,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001569411,"about_ca_topic_score_gemma":0.001075776,"domain_scores_codex":[0.9966828,0.00005865959,0.0004463597,0.0009150153,0.001029796,0.0008673247],"domain_scores_gemma":[0.9979786,0.0004811561,0.0001474483,0.0008069983,0.0001851142,0.0004007086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.2189756,0.007646007,0.1398528,0.004088153,0.01120686,0.002501465,0.0177683,0.09098915,0.002404806,0.001659092,0.03239895,0.4705089],"study_design_scores_gemma":[0.2854659,0.02341206,0.001687272,0.0003358521,0.0008683968,0.0000550033,0.0005060699,0.005382934,0.007415304,0.0002517837,0.6738424,0.0007770137],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908908,0.003715027,0.0001214614,0.0002416997,0.0006442418,0.003089224,0.0006769529,0.0001664774,0.0004541434],"genre_scores_gemma":[0.9869521,0.0003818549,0.001832689,0.0002875007,0.0004930144,0.001934256,0.0007704765,0.0001205604,0.007227581],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6414434,"threshold_uncertainty_score":0.9999261,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4376872039","doi":"10.1182/bloodadvances.2023010177","title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Impact; University of Calgary; Cochrane","funders":"","keywords":"Thrombophilia; Medicine; Guideline; Family history; Intensive care medicine; Venous thromboembolism; Population; Thrombosis; Venous thrombosis; Factor V Leiden; Risk assessment; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0930723388499114,"gpt":0.3781031772352406,"spread":0.2850308383853292,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003508492,0.0002211753,0.001247524,0.0001204245,0.00009066364,0.000005846293,0.0002024759,0.00004939842,0.00001960898],"category_scores_gemma":[0.0001243306,0.0001945091,0.0002749682,0.0009216045,0.0002702222,0.00007877769,0.0001602986,0.00006700764,0.00001146606],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001462992,"about_ca_system_score_gemma":0.00004297828,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007800007,"about_ca_topic_score_gemma":0.000009952054,"domain_scores_codex":[0.9981045,0.00001782851,0.0007153696,0.000398865,0.0003325049,0.0004309197],"domain_scores_gemma":[0.9983999,0.0002087605,0.0004531025,0.0004079592,0.0004554522,0.00007487087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0003328504,0.01307345,0.0589276,0.04813572,0.01439642,0.0002168713,0.002779419,0.003928186,0.05314165,0.0575145,0.2346804,0.5128729],"study_design_scores_gemma":[0.01453146,0.01296009,0.6429123,0.007968338,0.0107935,0.0001317468,0.03100949,0.004091622,0.09110225,0.0248201,0.1576043,0.00207485],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9769552,0.00746596,0.001028522,0.004667756,0.0006513351,0.002871555,0.0001395554,0.0003944881,0.005825682],"genre_scores_gemma":[0.7732539,0.01694778,0.2064015,0.001372586,0.0004319426,0.0005536648,0.0001207307,0.0001191655,0.0007987854],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5839847,"threshold_uncertainty_score":0.7931853,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2668200717","doi":"10.1182/bloodadvances.2017004820","title":"Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: results of the REDS-III RBC-Omics study","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood groups and transfusion","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Victoria; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; RTI International; National Institutes of Health; Blood Systems Research Institute; University of California, San Francisco; Institute For Transfusion Medicine; University of Pittsburgh","keywords":"Hemolysis; Ethnic group; Red blood cell; Omics; Medicine; Genetic predisposition; Gerontology; Biology; Immunology; Demography; Internal medicine; Bioinformatics; Political science","retraction":null,"screen_n_in":null,"score":{"opus":0.01610343930907197,"gpt":0.2755476419641554,"spread":0.2594442026550834,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003272456,0.0001933864,0.0006246866,0.00005105588,0.0002489191,0.00002477676,0.0002431753,0.00009069072,0.000001513703],"category_scores_gemma":[0.0001150209,0.0001300631,0.00007350164,0.00007366628,0.0002948506,0.0001494515,0.0002039834,0.000188384,8.912109e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000003026802,"about_ca_system_score_gemma":0.00002537452,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002487936,"about_ca_topic_score_gemma":0.001463418,"domain_scores_codex":[0.998575,0.00007072436,0.0004659159,0.0003812647,0.0003063512,0.0002007904],"domain_scores_gemma":[0.9982898,0.00008264471,0.0006198409,0.0008365074,0.00007842877,0.00009274174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006475116,0.002834699,0.9482997,0.0007532133,0.0001891209,0.0002451082,0.002551486,0.000004310844,0.03846781,0.000003997741,0.00000792524,0.005995095],"study_design_scores_gemma":[0.01454152,0.001070896,0.6767619,0.0006256146,0.001503888,0.00003722348,0.002518297,0.00002052745,0.3026217,0.00007686565,0.00005982041,0.000161759],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954394,0.003053487,0.000001787973,0.0001171118,0.00009497934,0.0006368696,0.0001586449,0.00001315671,0.0004845471],"genre_scores_gemma":[0.9980129,0.001374383,0.0002208616,0.00001725606,0.00005581856,0.000008591172,0.000003654111,0.00001865583,0.0002878656],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2715378,"threshold_uncertainty_score":0.5303817,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2774435803","doi":"10.1182/bloodadvances.2017012310","title":"Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Medicine; Gastroenterology; Internal medicine; Confidence interval; Macrophage activation syndrome; Area under the curve; Sepsis; Receiver operating characteristic; Immunology; Malignancy; Ferritin; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.01347811286519576,"gpt":0.3048526428598813,"spread":0.2913745299946856,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000150906,0.0001549004,0.0003455383,0.00009782362,0.00021756,0.00006162059,0.0002091298,0.00007432655,0.0002300687],"category_scores_gemma":[0.005111322,0.0001331002,0.00007386797,0.00007731272,0.0002277288,0.0004340452,0.0001280452,0.0002808933,0.0003675176],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002887108,"about_ca_system_score_gemma":0.0001212691,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001572869,"about_ca_topic_score_gemma":0.0002261157,"domain_scores_codex":[0.9987722,0.00002543845,0.0002805272,0.000302439,0.0002542005,0.0003651897],"domain_scores_gemma":[0.9986606,0.0004071857,0.000138868,0.0005300578,0.0001707477,0.00009249398],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002991758,0.001335878,0.8691363,0.0004381326,0.0001300398,0.000635026,0.00248771,0.000002691536,0.0173243,0.0002642979,0.006893918,0.1010526],"study_design_scores_gemma":[0.01413261,0.002166565,0.4299087,0.003363293,0.0001647199,0.000113992,0.004517347,0.0003344004,0.2404907,0.000530612,0.3033867,0.0008902795],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9701631,0.00226833,0.00001329157,0.00419027,0.0002523382,0.0005747683,0.00001789436,0.00005916823,0.02246081],"genre_scores_gemma":[0.9899664,0.003818308,0.0003431689,0.0005587597,0.0001299555,0.00006285023,0.00001244467,0.00002464038,0.005083451],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4392276,"threshold_uncertainty_score":0.61191,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3047569349","doi":"10.1182/bloodadvances.2020001920","title":"American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Grand River Hospital; McMaster University; Health Sciences Centre; Impact","funders":"","keywords":"Medicine; Guideline; Intensive care medicine; Hematology; Myeloid leukemia; Supportive psychotherapy; Internal medicine; Disease; Family medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02674448791496178,"gpt":0.3442270041501308,"spread":0.317482516235169,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001726715,0.0002559536,0.0008951076,0.00006308198,0.00005238403,0.000008871842,0.000239855,0.00009871845,0.00003122725],"category_scores_gemma":[0.001088541,0.000215493,0.0002502273,0.0006947147,0.000250168,0.0001543149,0.0001028983,0.0002769472,0.00000662671],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001417376,"about_ca_system_score_gemma":0.0005606069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002699827,"about_ca_topic_score_gemma":0.00007367416,"domain_scores_codex":[0.9978636,0.00004561046,0.0007241803,0.0005499383,0.0003108864,0.0005058217],"domain_scores_gemma":[0.9983014,0.0005133973,0.000297548,0.0002559492,0.0004110631,0.0002206832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007287008,0.0009807284,0.2717573,0.006485329,0.001998436,0.0009359974,0.01358113,0.00131122,0.10802,0.0002680829,0.1185085,0.4688663],"study_design_scores_gemma":[0.1410004,0.01203753,0.05269722,0.004540042,0.002091238,0.0006968114,0.0479677,0.1347083,0.5116736,0.0003567358,0.08960801,0.002622508],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9751028,0.004240569,0.001167421,0.01781169,0.00004735219,0.001269338,0.00007461834,0.00009529955,0.0001909374],"genre_scores_gemma":[0.7765596,0.00759578,0.2053659,0.008621874,0.0008524862,0.0004638638,0.0001526036,0.0001051565,0.0002827417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4662438,"threshold_uncertainty_score":0.8787549,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3213050308","doi":"10.1182/bloodadvances.2021005794","title":"Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada); Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Bendamustine; Hazard ratio; Internal medicine; Cohort; Confidence interval; Rituximab; Clinical endpoint; Randomized controlled trial; Oncology; Surgery; Lymphoma","retraction":null,"screen_n_in":null,"score":{"opus":0.03337199370905094,"gpt":0.2962263346243567,"spread":0.2628543409153058,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001373225,0.0002073554,0.000500733,0.00006748074,0.00006925497,0.00003379288,0.00007915832,0.00007560234,0.00003816787],"category_scores_gemma":[0.0002383379,0.0001728412,0.00002688781,0.0001616408,0.00006908099,0.0002378883,0.0002540062,0.0001334055,0.00001016231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005312185,"about_ca_system_score_gemma":0.0002884361,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003084796,"about_ca_topic_score_gemma":0.0006714252,"domain_scores_codex":[0.9985003,0.0000491582,0.0002816886,0.000680273,0.0002379687,0.0002506375],"domain_scores_gemma":[0.9989121,0.000154871,0.00008082962,0.0005850638,0.00005139393,0.0002157691],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00042414,0.004278649,0.8411232,0.0002022741,0.0002680381,0.00311029,0.0001853373,0.000004749207,0.001224566,0.0004935824,0.0008404733,0.1478447],"study_design_scores_gemma":[0.04240524,0.0003515664,0.8882309,0.0004726199,0.0006642112,0.0005638583,0.000346644,0.0002097153,0.002367157,0.0002995642,0.06377602,0.0003125065],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8902329,0.1074911,0.00001052886,0.001293846,0.0002182242,0.0002348273,0.00005904029,0.00003840905,0.0004211114],"genre_scores_gemma":[0.9681491,0.02636807,0.004200771,0.0003494575,0.000198838,0.000009677098,0.0004391072,0.00002505243,0.0002599774],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1475322,"threshold_uncertainty_score":0.7048258,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2991882427","doi":"10.1182/bloodadvances.2019000916","title":"American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute; American Heart Association; Mayo Clinic","keywords":"Hematology; Medicine; Disease; Internal medicine; Intensive care medicine; Kidney disease; Kidney; Cardiology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.01054262073199798,"gpt":0.2810765644987329,"spread":0.270533943766735,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006787106,0.0001492594,0.0004249636,0.00002943634,0.00004449251,0.000003908935,0.00006143525,0.00004126171,0.00002003877],"category_scores_gemma":[0.00009838939,0.0001139557,0.0002158658,0.0001058076,0.000200358,0.00007081805,0.00003911668,0.00006962918,0.000005253936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005204833,"about_ca_system_score_gemma":0.000158819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002140445,"about_ca_topic_score_gemma":3.99502e-7,"domain_scores_codex":[0.9990609,0.00001518053,0.0002676115,0.0002891997,0.0001432027,0.0002239264],"domain_scores_gemma":[0.9990318,0.00005754782,0.0001304794,0.0002478384,0.0001580682,0.0003742219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001720878,0.001173336,0.8663882,0.007863676,0.0005212377,0.00005459551,0.0002241525,0.0003082925,0.009629329,0.0004901873,0.09430935,0.01731674],"study_design_scores_gemma":[0.01013816,0.001242322,0.03902936,0.0009557554,0.002226901,0.00005317804,0.002603686,0.002752979,0.004696762,0.0009583004,0.9345652,0.0007773493],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8331246,0.1506287,0.0002526904,0.0130455,0.0003510937,0.001302282,0.0004198506,0.00008537974,0.0007899384],"genre_scores_gemma":[0.9468794,0.03059736,0.01162696,0.005252584,0.0002582533,0.00007712295,0.0002694744,0.00006646408,0.004972386],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8402559,"threshold_uncertainty_score":0.4646978,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3093284859","doi":"10.1182/bloodadvances.2020002623","title":"The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood groups and transfusion","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Blood Services; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia, Okanagan Campus; International Collaboration On Repair Discoveries; University of British Columbia","funders":"National Institutes of Health; Michael Smith Health Research BC; Weston Brain Institute; Vancouver Coastal Health Research Institute; Heart and Stroke Foundation of Canada","keywords":"Medicine; ABO blood group system; Mechanical ventilation; Intensive care unit; Internal medicine; Comorbidity; Renal replacement therapy; Prospective cohort study; Cohort study","retraction":null,"screen_n_in":null,"score":{"opus":0.006850865591322744,"gpt":0.2349400243198143,"spread":0.2280891587284916,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001750488,0.00008867115,0.0002091379,0.00003417241,0.00006771481,0.000008137738,0.0000434934,0.00004161835,0.000006392571],"category_scores_gemma":[0.0002209961,0.00005741084,0.00002930687,0.0002410854,0.00007454536,0.0001653249,0.00001435935,0.0001092259,2.477005e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001089729,"about_ca_system_score_gemma":0.00006291771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001067923,"about_ca_topic_score_gemma":0.0006101584,"domain_scores_codex":[0.9991937,0.00004758549,0.0002150813,0.0001767184,0.0002572907,0.0001096066],"domain_scores_gemma":[0.9993601,0.0001616878,0.0001869004,0.0000899646,0.00004819651,0.0001531582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001038082,0.0004185977,0.9892519,0.0005551087,0.00009430743,0.00001120536,0.000720759,0.00001555234,0.00441596,0.0001213595,0.000004224035,0.003353017],"study_design_scores_gemma":[0.008708403,0.0009062765,0.9813612,0.0001594429,0.0006901441,0.000004405818,0.0006991465,0.00006715621,0.005464213,0.0001454413,0.001695714,0.0000984342],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933019,0.003672183,0.0000957439,0.002482949,0.00002864235,0.0003157826,0.00002365738,0.00002027939,0.00005889352],"genre_scores_gemma":[0.9970304,0.002321105,0.0002704341,0.0002876856,0.0000463145,0.00001160298,0.00001421333,0.000007870808,0.00001036435],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007890604,"threshold_uncertainty_score":0.2341146,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2948352962","doi":"10.1182/bloodadvances.2018030387","title":"Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update","year":2019,"lang":"en","type":"review","venue":"Blood Advances","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Cilag; National Cancer Institute; Italfarmaco; Ipsen; Servier; Kyowa Hakko Kirin; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Daiichi Sankyo Europe; Sanofi; Biogen; Celgene; American Society of Clinical Oncology; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Biosimilar; Anemia; Randomized controlled trial; Internal medicine; Cancer; Intensive care medicine; Epoetin alfa; Guideline; Cochrane Library; Oncology; Myelodysplastic syndromes; Clinical trial; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.05770829144142951,"gpt":0.4484844334443418,"spread":0.3907761420029123,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007494678,0.0007984659,0.003545001,0.0001377565,0.0001090893,0.00002840288,0.0003091636,0.0003780898,0.0003465001],"category_scores_gemma":[0.0002720199,0.0005384833,0.0006746894,0.0005824608,0.0002348397,0.0002235346,0.0001891214,0.0006440967,0.00008772591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002083503,"about_ca_system_score_gemma":0.0004853665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000844205,"about_ca_topic_score_gemma":0.0000281609,"domain_scores_codex":[0.9948485,0.0002768546,0.002428418,0.001009978,0.0008772422,0.0005590178],"domain_scores_gemma":[0.9951929,0.0005806845,0.002662492,0.0008899123,0.0004645601,0.0002094508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001331115,0.002247459,0.001124371,0.03973118,0.006181315,0.0009768184,0.00003023705,0.00004191543,1.923779e-7,0.00007941829,0.003318484,0.9461355],"study_design_scores_gemma":[0.003924587,0.00109573,0.00004984503,0.05780298,0.0299191,0.0001105169,0.0002598247,0.000007476061,0.000004446863,0.000005281153,0.9063381,0.0004821446],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001050892,0.9895404,0.00002811638,0.0006188178,0.0005302766,0.002079604,0.0001627439,0.0001210504,0.006813929],"genre_scores_gemma":[0.0000331592,0.950579,0.04528057,0.0003922802,0.0003351991,0.0001342615,0.0007668438,0.0001347357,0.002343937],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9456534,"threshold_uncertainty_score":0.9997067,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3205877886","doi":"10.1182/bloodadvances.2021005808","title":"Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Warfarin; Medicine; Apixaban; Antiphospholipid syndrome; Thrombosis; Randomized controlled trial; Internal medicine; Cardiology; Rivaroxaban; Atrial fibrillation","retraction":null,"screen_n_in":null,"score":{"opus":0.0244644006078143,"gpt":0.320748659133729,"spread":0.2962842585259147,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008231519,0.0002956517,0.001884531,0.0002087514,0.00006513284,0.00004886588,0.000204492,0.00008614727,0.000234421],"category_scores_gemma":[0.0007117775,0.0002108075,0.0001970038,0.000962257,0.000154447,0.0001535536,0.0001206318,0.0002714748,0.00007196577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001030627,"about_ca_system_score_gemma":0.0004255002,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008435956,"about_ca_topic_score_gemma":0.0002214993,"domain_scores_codex":[0.9967817,0.0003937426,0.0007273134,0.0006605035,0.0008580104,0.0005787318],"domain_scores_gemma":[0.9981988,0.0005540073,0.0001423983,0.0006468826,0.000187578,0.0002703116],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8597479,0.01020802,0.100683,0.003514736,0.002439325,0.004139658,0.006466375,0.0004188722,0.01027664,0.0005982844,0.0005760208,0.0009311771],"study_design_scores_gemma":[0.9688838,0.001012111,0.001986199,0.003139922,0.0004229823,0.00684661,0.001623889,0.00008421778,0.01481601,0.0001598529,0.0006517713,0.0003727132],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884506,0.004322199,0.0001310474,0.0008644927,0.0003350711,0.004051028,0.00000813304,0.00008492447,0.001752444],"genre_scores_gemma":[0.9932486,0.0005753195,0.004111697,0.0001547448,0.0001120035,0.0006214422,0.00002284745,0.00005086067,0.001102464],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1091359,"threshold_uncertainty_score":0.8596479,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2969918675","doi":"10.1182/bloodadvances.2018024729","title":"Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Baycrest Hospital; University of Toronto; Health Sciences Centre; Queen's University","funders":"Ontario Institute for Cancer Research; Southeastern Ontario Academic Medical Organization; Canadian Cancer Society Research Institute; European Hematology Association","keywords":"Haematopoiesis; Inflammation; Immunology; Interleukin 6; Medicine; Biology; Bioinformatics; Stem cell; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.007020401147990897,"gpt":0.254749389596823,"spread":0.2477289884488321,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001024217,0.00009077562,0.0003585017,0.00008198273,0.00001350956,0.000003062916,0.00008019058,0.00004943013,0.0001114545],"category_scores_gemma":[0.0000833091,0.00007589943,0.00003986304,0.000091198,0.0001711795,0.0000613201,0.00006228135,0.0001002181,0.00001313112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000108072,"about_ca_system_score_gemma":0.0001177997,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008360044,"about_ca_topic_score_gemma":0.000002195168,"domain_scores_codex":[0.9991525,0.00002126729,0.0002872267,0.0001470233,0.0002476709,0.0001443111],"domain_scores_gemma":[0.9993252,0.000120876,0.0001437523,0.0002203828,0.0001226389,0.00006718658],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001589635,0.00009258764,0.9126272,0.001376598,0.00008411456,0.00002403352,0.0001226985,0.000001091208,0.0816434,0.0004196571,0.00002645205,0.003423173],"study_design_scores_gemma":[0.001517874,0.0003619702,0.8915738,0.0002141352,0.00009636635,0.00009441493,0.000133372,0.00004687313,0.1029804,0.0001267919,0.002759891,0.00009413734],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953555,0.003241602,0.00001003654,0.00007089034,0.00004551389,0.000226387,0.00002086788,0.00001189702,0.001017311],"genre_scores_gemma":[0.9957915,0.001190101,0.002587405,0.00003402472,0.0000519337,0.000005230849,0.00000724567,0.00001359527,0.0003189535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02133698,"threshold_uncertainty_score":0.3095089,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3111140326","doi":"10.1182/bloodadvances.2020003170","title":"Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Hydroxychloroquine; Internal medicine; Multiple myeloma; Hematologic disease; Hematology; Disease; Cancer; Incidence (geometry); Intensive care medicine; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","retraction":null,"screen_n_in":null,"score":{"opus":0.1936404149614515,"gpt":0.4618986584622338,"spread":0.2682582435007823,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0004313883,0.0001277377,0.0004353798,0.00003735562,0.0001684781,0.0000210303,0.0002383146,0.00004808542,0.00003158697],"category_scores_gemma":[0.009054977,0.00006718324,0.00001696131,0.0004688755,0.0003620643,0.0001925753,0.0002469914,0.0001936213,0.000002107578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002150009,"about_ca_system_score_gemma":0.001137457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004697253,"about_ca_topic_score_gemma":0.0007596499,"domain_scores_codex":[0.9982798,0.0001372682,0.0003123411,0.0004256715,0.0006060429,0.0002388741],"domain_scores_gemma":[0.9970031,0.001424454,0.0002007143,0.0006251748,0.0004019437,0.0003446287],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004113524,0.0001297085,0.9935181,0.0003018198,0.00009653283,0.0002259847,0.001968445,0.000001627154,0.00005408974,0.00007166428,0.002874866,0.0003457692],"study_design_scores_gemma":[0.002799314,0.0009716197,0.917089,0.0001336054,0.000139122,0.00002323697,0.003674913,0.000007674902,0.0005647772,0.0004157407,0.07406405,0.0001169735],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9218724,0.005717629,0.0000723175,0.07032008,0.00003302694,0.0009425704,0.0008476778,0.00004106658,0.0001532525],"genre_scores_gemma":[0.9895118,0.0005085653,0.001237457,0.008376176,0.000057327,0.00002039221,0.0002406811,0.00001148819,0.00003604202],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07642917,"threshold_uncertainty_score":0.9992922,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3006233208","doi":"10.1182/bloodadvances.2019000525","title":"Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Hospital","funders":"Legend Biotech; Novartis Pharmaceuticals Corporation","keywords":"Cytokine release syndrome; Immunogenicity; Immunology; Medicine; CD19; Hazard ratio; Internal medicine; Tocilizumab; Oncology; Biology; Immunotherapy; Flow cytometry; Cancer; Antibody; Confidence interval; Chimeric antigen receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.0500624111526647,"gpt":0.3459240145316899,"spread":0.2958616033790252,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003746534,0.0001672844,0.0004161303,0.0001453274,0.00002668359,0.00001767875,0.0001219391,0.0001481467,0.0002518478],"category_scores_gemma":[0.0007239014,0.0001555582,0.00007587279,0.0004530547,0.00009309215,0.0001196574,0.00009282659,0.0005807648,0.00002909013],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005216147,"about_ca_system_score_gemma":0.00006034854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007939509,"about_ca_topic_score_gemma":0.000141152,"domain_scores_codex":[0.9981771,0.0001591547,0.0005738501,0.000461602,0.0003228518,0.0003054246],"domain_scores_gemma":[0.9990757,0.0002896359,0.00007724372,0.0002415223,0.0000469105,0.0002690105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006987373,0.0005586881,0.6938382,0.00006064247,0.00002932985,0.0001005795,0.0009171981,0.00003043992,0.2885427,0.00001055707,0.00002587438,0.015187],"study_design_scores_gemma":[0.006247113,0.001583162,0.9286353,0.00009639604,0.0000346689,0.000004458805,0.0002913046,0.0001065733,0.03796007,0.00007460302,0.02476414,0.0002021956],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924583,0.004899353,0.00002751218,0.0009616996,0.0001271362,0.0005852105,0.000006401986,0.00003733747,0.0008969781],"genre_scores_gemma":[0.9969556,0.001352627,0.0006851685,0.0003763983,0.0001787822,0.00001238716,0.00001747371,0.00003028343,0.0003912172],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2505827,"threshold_uncertainty_score":0.6343479,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3092660013","doi":"10.1182/bloodadvances.2020002650","title":"Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":140,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of Alberta","funders":"","keywords":"Cytokine storm; Immunology; Proinflammatory cytokine; Cytolysis; Natural killer cell; Cytokine; Interleukin; Interleukin 21; Interleukin 12; Medicine; IL-2 receptor; Biology; T cell; Disease; Inflammation; Coronavirus disease 2019 (COVID-19); Internal medicine; Immune system; Cytotoxicity; Cytotoxic T cell; Infectious disease (medical specialty)","retraction":null,"screen_n_in":null,"score":{"opus":0.006811501531896344,"gpt":0.2133110984926539,"spread":0.2064995969607575,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001843378,0.00007577072,0.00009896846,0.00002387157,0.00005137767,0.000006175289,0.00003596845,0.00004586765,0.000365977],"category_scores_gemma":[0.00002916681,0.00005855551,0.00001382497,0.0000577455,0.00003896519,0.0001556923,0.00001694579,0.000142975,0.0001207207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001546839,"about_ca_system_score_gemma":0.00002456793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001199448,"about_ca_topic_score_gemma":0.000008049648,"domain_scores_codex":[0.9996347,0.00003715209,0.00006716591,0.0001411391,0.00001916601,0.0001006967],"domain_scores_gemma":[0.9998366,0.00003446406,0.00004608269,0.00005035705,0.00001392526,0.00001855086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008037117,0.001553129,0.8390484,0.0004445955,0.0003208579,0.00002346883,0.002671786,0.00009903253,0.08353405,0.0001194736,0.04412181,0.02002623],"study_design_scores_gemma":[0.01252123,0.001161467,0.1902373,0.00003910932,0.0000737406,0.0000259427,0.000368545,0.0000274964,0.02487883,0.00002213282,0.7701593,0.0004849018],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946409,0.00197782,0.00001799435,0.000309784,0.0009647533,0.0001446514,0.000003681904,0.00004117769,0.00189925],"genre_scores_gemma":[0.9965791,0.00005887962,0.00001466308,0.0007349654,0.00001059989,0.000003659986,0.0000279698,0.000005183706,0.002565021],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7260375,"threshold_uncertainty_score":0.4007191,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2772326091","doi":"10.1182/bloodadvances.2017010942","title":"Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Amgen Canada","keywords":"Medicine; Interquartile range; Immune thrombocytopenia; Confidence interval; Hematology; Severe bleeding; Pediatrics; Internal medicine; Surgery; Platelet","retraction":null,"screen_n_in":null,"score":{"opus":0.02847892635415331,"gpt":0.2967831409619002,"spread":0.2683042146077469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000598612,0.0001148875,0.000478635,0.00001450572,0.0001360861,0.00001734558,0.0001874944,0.00004968095,0.00005628557],"category_scores_gemma":[0.00009324385,0.00007178183,0.00006436274,0.00002638155,0.0002749323,0.0001856804,0.00007296261,0.0000774985,0.000001701607],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005801493,"about_ca_system_score_gemma":0.00003421484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006848003,"about_ca_topic_score_gemma":0.00009548605,"domain_scores_codex":[0.9993287,0.00001152129,0.0002116716,0.0001812193,0.0001449654,0.0001219787],"domain_scores_gemma":[0.9990442,0.0001240017,0.0003124097,0.00043779,0.00004372003,0.00003782621],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001164199,0.0006717006,0.8921431,0.0001936321,0.0006179346,0.00009928337,0.0004416142,3.237768e-7,0.07541447,0.0002699512,0.0001438887,0.02988763],"study_design_scores_gemma":[0.002967813,0.000182794,0.9344174,0.0004608169,0.0005457288,0.00002820879,0.0002466901,0.000001089317,0.05856781,0.00154948,0.0009436611,0.00008845558],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9608012,0.02906913,0.000002359135,0.001783327,0.00006198483,0.0001865445,0.00008571904,0.000007459004,0.008002221],"genre_scores_gemma":[0.9933975,0.00495134,0.001285966,0.00007137785,0.00003826681,0.00001156957,0.00001704232,0.00001007156,0.0002168213],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0422743,"threshold_uncertainty_score":0.2927178,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2765241801","doi":"10.1182/bloodadvances.2017007021","title":"Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Canadian Blood Services; University of Toronto; Centre hospitalier universitaire de Québec; St. Michael's Hospital","funders":"Health Canada; Hospital for Sick Children; China Scholarship Council; University of Toronto; Canadian Blood Services; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Institutes of Health; National Science Foundation","keywords":"Antigen; Antigen processing; CD8; Cell biology; MHC class I; Major histocompatibility complex; Platelet; MHC restriction; MHC class II; In vitro; Biology; Chemistry; Immunology; Molecular biology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.0133673952817504,"gpt":0.2685148947305223,"spread":0.2551474994487719,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003958405,0.0002299981,0.000380667,0.00005449724,0.0002218119,0.00007782629,0.0001616579,0.00007159319,0.00004506119],"category_scores_gemma":[0.00002332418,0.0001696904,0.00006035153,0.00005181618,0.00005427925,0.0001730737,0.00006740615,0.00009992986,0.00006014883],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007942292,"about_ca_system_score_gemma":0.00002053701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004456559,"about_ca_topic_score_gemma":0.00005804243,"domain_scores_codex":[0.9989032,0.00001102899,0.0001570997,0.0003920364,0.0002138528,0.0003227982],"domain_scores_gemma":[0.9992017,0.00002895184,0.00003241415,0.0004195439,0.00004070408,0.0002767341],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004828065,0.006523692,0.1443607,0.001475385,0.003124838,0.01823386,0.005315908,0.0003970095,0.5530292,0.001846962,0.008098028,0.2527663],"study_design_scores_gemma":[0.005614153,0.000995049,0.06414433,0.000358974,0.0002809056,0.000362895,0.0001863247,0.00003133401,0.7231217,0.0005304487,0.2038832,0.0004906896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869202,0.003582356,0.00004970584,0.003214689,0.0001241399,0.0006423617,0.00006610621,0.00004921647,0.005351271],"genre_scores_gemma":[0.9935729,0.002238388,0.002208177,0.0005635325,0.00009921312,0.0000406581,0.00001290674,0.00002833751,0.001235908],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2522756,"threshold_uncertainty_score":0.6919774,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2952209878","doi":"10.1182/bloodadvances.2019000050","title":"Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; U.S. Navy; Astellas Pharma; Incyte; bluebird bio; Gilead Sciences; Actinium Pharmaceuticals; Atara Biotherapeutics; Bristol-Myers Squibb; Cerus Corporation; Angiocrine Bioscience; HistoGenetics; National Institute of Allergy and Infectious Diseases; Celgene; National Institutes of Health; U.S. Department of Health and Human Services; Health Resources and Services Administration; Astellas Pharma US; Amgen; U.S. Department of Defense","keywords":"Medicine; Calcineurin; Internal medicine; Hazard ratio; Myeloid leukemia; Cyclophosphamide; Transplantation; Gastroenterology; Oncology; Incidence (geometry); Confidence interval; Hematopoietic stem cell transplantation; Surgery; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01745137458688331,"gpt":0.2998237493191309,"spread":0.2823723747322475,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001840091,0.0001534674,0.0005308865,0.0001629685,0.00003166618,0.000008557946,0.00008545197,0.00009118141,0.00005062684],"category_scores_gemma":[0.0000349307,0.0001308083,0.0001075616,0.0001813422,0.00003424719,0.0001860812,0.000006046204,0.00009901251,0.00001656051],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004955141,"about_ca_system_score_gemma":0.00007351687,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002491919,"about_ca_topic_score_gemma":0.00004788288,"domain_scores_codex":[0.9986791,0.00002054861,0.0005192418,0.0002708921,0.0002865956,0.0002235937],"domain_scores_gemma":[0.9991572,0.0004021492,0.0001283638,0.0001758661,0.00006604659,0.00007031367],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001672733,0.0001799557,0.7270798,0.005050714,0.0001888884,0.00005202442,0.001689017,0.0003990004,0.2624692,0.0005188677,0.000009326938,0.0006905111],"study_design_scores_gemma":[0.01909409,0.0007850659,0.5884347,0.002791886,0.001376894,0.0001978281,0.0006420159,0.00259684,0.3819354,0.0008161037,0.0009061015,0.0004230207],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937257,0.0002096007,0.004021268,0.0003471742,0.0001637725,0.0009170427,0.00004997717,0.00004245536,0.000522967],"genre_scores_gemma":[0.9855521,0.0008246385,0.01302957,0.00008585727,0.00002754724,0.00004016421,0.0001352503,0.00002493922,0.0002799342],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1386451,"threshold_uncertainty_score":0.5334209,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3013483274","doi":"10.1182/bloodadvances.2019000960","title":"Diagnosis of deep vein thrombosis of the lower extremity: a systematic review and meta-analysis of test accuracy","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; Impact; University of Calgary; Western University; McMaster University; University of Ottawa; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Meta-analysis; Confidence interval; Deep vein; Pulmonary embolism; Thrombosis; MEDLINE; Internal medicine; Diagnostic accuracy; Publication bias; Venous thrombosis; Grading (engineering); Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.06191163969537646,"gpt":0.3521576731789797,"spread":0.2902460334836032,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0005562132,0.0005341488,0.01837824,0.0002514105,0.0000402853,0.00001060946,0.0005204425,0.0001195306,0.0003285085],"category_scores_gemma":[0.003178771,0.0002759091,0.004310015,0.001934483,0.0001912362,0.0001005999,0.0003043516,0.000199609,0.000002586541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002124556,"about_ca_system_score_gemma":0.00008746355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003153241,"about_ca_topic_score_gemma":0.00003855585,"domain_scores_codex":[0.9960585,0.000328926,0.002242401,0.0005280948,0.0006327194,0.0002093418],"domain_scores_gemma":[0.9927272,0.002394833,0.003314614,0.001245046,0.0002176963,0.0001006697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[6.288517e-7,0.00110799,0.00008423234,0.8139377,0.1770058,0.000003932697,0.00005072881,6.736026e-7,3.394205e-7,0.00006569905,0.00009038555,0.007651906],"study_design_scores_gemma":[0.0001128219,0.0001402098,0.00006801752,0.1010909,0.8512735,0.000004336945,0.00003152724,0.000001089051,0.00001401658,0.000009509923,0.04707635,0.000177711],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008629545,0.9945638,0.000005405215,0.0004185801,0.0000394265,0.004416087,0.0002882235,0.00001390319,0.0002459406],"genre_scores_gemma":[0.0005664621,0.9976032,0.0002395961,0.0003612103,0.00001708669,0.001110295,0.00002341227,0.00004046813,0.00003822297],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7128468,"threshold_uncertainty_score":0.9999693,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4318762955","doi":"10.1182/bloodadvances.2022009411","title":"Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory <i>IDH1</i>-mutated AML","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Refractory (planetary science); Medicine; Internal medicine; IDH1; Oncology; Gastroenterology; Cancer research; Mutation; Biology; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02551476272836265,"gpt":0.2973823733911226,"spread":0.2718676106627599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003437058,0.0003076279,0.0005711545,0.0004758352,0.0002038165,0.0000355676,0.0003197536,0.0001517564,0.0001944589],"category_scores_gemma":[0.0008161952,0.0002069247,0.00005875763,0.002040439,0.0001917868,0.000470447,0.0001493884,0.0007578497,0.0002229711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001987046,"about_ca_system_score_gemma":0.0005702322,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001271657,"about_ca_topic_score_gemma":0.0001409758,"domain_scores_codex":[0.9970257,0.0001382947,0.0004994891,0.0006224563,0.000912157,0.0008018548],"domain_scores_gemma":[0.9982457,0.0004441883,0.0001764793,0.0005574718,0.0002390878,0.000337096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01409542,0.003343356,0.8024785,0.001122133,0.0007439816,0.005076439,0.002211785,0.0007105297,0.124729,0.00007953636,0.02566186,0.01974753],"study_design_scores_gemma":[0.03758067,0.00449693,0.8340235,0.002127628,0.000286016,0.0001060558,0.001735838,0.000238373,0.02453924,0.0002923863,0.09352715,0.001046222],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951952,0.0004312312,0.000003751919,0.001151581,0.00010461,0.0008928885,0.00007054221,0.0003240325,0.001826165],"genre_scores_gemma":[0.992395,0.0007299483,0.001410974,0.0003864503,0.0001087297,0.0001142441,0.000368957,0.00008865864,0.004397045],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1001897,"threshold_uncertainty_score":0.8438146,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3085980128","doi":"10.1182/bloodadvances.2020002662","title":"ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sierra Wireless (Canada); Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Hepcidin; Anemia; Myelofibrosis; Medicine; Erythropoiesis; Internal medicine; Neutropenia; Gastroenterology; Ruxolitinib; Ineffective erythropoiesis; Bone marrow; Immunology; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.02558340270021353,"gpt":0.3067703012933573,"spread":0.2811868985931438,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001001327,0.0003065614,0.0006392504,0.0001001166,0.0001051196,0.00003911714,0.0000760507,0.0001048721,0.0002616582],"category_scores_gemma":[0.0002770692,0.0002420913,0.0001082604,0.000288604,0.00007644391,0.0003547762,0.00004171434,0.0001908924,0.00001533566],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000220982,"about_ca_system_score_gemma":0.00008814046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004655989,"about_ca_topic_score_gemma":0.0001367451,"domain_scores_codex":[0.9981797,0.00008586994,0.0004706369,0.0006067465,0.0003433063,0.0003137337],"domain_scores_gemma":[0.9991537,0.0002354778,0.0001011031,0.000164959,0.00005796012,0.0002867688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.123694,0.01751519,0.4514889,0.002249169,0.0007700066,0.001998724,0.008979547,0.00004298965,0.2422023,0.0006001896,0.002108472,0.1483506],"study_design_scores_gemma":[0.2452049,0.01205928,0.01030847,0.0006578992,0.0006607542,0.00007504999,0.001023358,0.00005827062,0.7011049,0.0001825473,0.02807165,0.0005928402],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867166,0.007149561,0.00001978027,0.003784227,0.0001937898,0.001446551,0.00008219732,0.00007750531,0.0005297589],"genre_scores_gemma":[0.9862211,0.01065707,0.001791824,0.0004688081,0.000467667,0.0002480156,0.00004928407,0.00003017764,0.00006610962],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4589027,"threshold_uncertainty_score":0.9872195,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2908990133","doi":"10.1182/bloodadvances.2018024133","title":"Management of direct factor Xa inhibitor–related major bleeding with prothrombin complex concentrate: a meta-analysis","year":2019,"lang":"en","type":"review","venue":"Blood Advances","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Meta-analysis; Internal medicine; Prothrombin complex concentrate; MEDLINE; Confidence interval; Thrombosis; Surgery; Gastroenterology; Warfarin; Atrial fibrillation","retraction":null,"screen_n_in":null,"score":{"opus":0.2077379151200556,"gpt":0.4014478521935785,"spread":0.1937099370735229,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002316686,0.0006510942,0.006448044,0.0004773267,0.00006644482,0.00004346769,0.0002199332,0.0001602747,0.001144092],"category_scores_gemma":[0.00001493171,0.0003927414,0.002752258,0.001711884,0.0001064724,0.0001965271,0.000110973,0.0001961214,0.00004698327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004950517,"about_ca_system_score_gemma":0.00006836261,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007521927,"about_ca_topic_score_gemma":0.000003134809,"domain_scores_codex":[0.9968274,0.0001350536,0.001242267,0.0007220988,0.0007088906,0.000364239],"domain_scores_gemma":[0.9976698,0.0001815106,0.001336583,0.0005866462,0.000117053,0.0001084711],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00009317596,0.0001091548,0.001773495,0.06912147,0.8567598,0.00007174217,0.00006558008,0.00004611853,0.000006879441,0.0009619953,0.00006900725,0.0709215],"study_design_scores_gemma":[0.0009552767,0.0001565171,0.0000782612,0.001284438,0.5305445,0.000003734336,0.00004318143,0.000004763047,0.00002675199,0.000005745158,0.4666052,0.0002917435],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005042658,0.9877704,0.00003535166,0.0000739422,0.0001481224,0.004570033,0.0001068375,0.0001060999,0.007138768],"genre_scores_gemma":[0.001438081,0.9861626,0.002114317,0.00001388682,0.0001277174,0.00007685772,0.0003868283,0.00007245695,0.00960725],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4665361,"threshold_uncertainty_score":0.9998524,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2996025285","doi":"10.1182/bloodadvances.2019000647","title":"How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Agence Nationale de la Recherche","keywords":"Internal medicine; Medicine; Vincristine; Immunophenotyping; Cyclophosphamide; Myeloid leukemia; Oncology; Transplantation; Leukemia; Myeloid; Lymphoma; Gastroenterology; Immunology; Chemotherapy; Antigen","retraction":null,"screen_n_in":null,"score":{"opus":0.01112126561000265,"gpt":0.2575552602353257,"spread":0.2464339946253231,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004791674,0.0002706002,0.0004148961,0.0001503066,0.00009573327,0.00008822302,0.0001094614,0.00008974682,0.0001246819],"category_scores_gemma":[0.0002900803,0.0002184399,0.00007586709,0.0001910138,0.0001462011,0.0002624767,0.00007648581,0.0002133953,0.0001101619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004193664,"about_ca_system_score_gemma":0.0000872874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009371071,"about_ca_topic_score_gemma":0.00005814919,"domain_scores_codex":[0.9982848,0.0000522637,0.0001851333,0.0005039319,0.0004996262,0.0004742851],"domain_scores_gemma":[0.9987471,0.0005079612,0.00006130222,0.0002918156,0.000148289,0.0002435147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003864929,0.001366164,0.9693754,0.001020361,0.00007652222,0.0002759379,0.0005038102,0.00001965343,0.008191655,0.00007412335,0.000419412,0.01829042],"study_design_scores_gemma":[0.09880669,0.02237829,0.1231256,0.00250847,0.002069555,0.003828711,0.01016144,0.002803768,0.4634674,0.002133949,0.2647387,0.003977434],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9831317,0.01035532,0.00001314955,0.001029335,0.0001358082,0.0009249699,0.00003500348,0.00006382779,0.004310876],"genre_scores_gemma":[0.9850008,0.003692069,0.0003064053,0.000188304,0.0000776039,0.00006652973,0.00003932245,0.00004578965,0.01058314],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8462498,"threshold_uncertainty_score":0.8907723,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3037474453","doi":"10.1182/bloodadvances.2020001696","title":"Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; Genome British Columbia; Spinal Cord Injury BC; Queen's University; McGill University; Princess Margaret Cancer Centre; Simon Fraser University","funders":"Fondation de l'Hôpital général juif; Jewish General Hospital; Terry Fox Research Institute; Cancer Research UK; Genome British Columbia; Michael Smith Health Research BC; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Genome Canada","keywords":"CHOP; Rituximab; Missense mutation; Vincristine; Lymphoma; Cancer research; Nonsense mutation; Biology; CD20; Mutation; Oncology; Immunology; Internal medicine; Medicine; Cyclophosphamide; Genetics; Chemotherapy; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.0106945703916324,"gpt":0.2319072049904035,"spread":0.2212126345987711,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001249128,0.0001190703,0.0002565231,0.00003411113,0.00002048339,0.000003036986,0.00003011983,0.00003077299,0.00001549102],"category_scores_gemma":[0.00001328544,0.00009217647,0.00004594915,0.00009101182,0.00003098872,0.0000336536,0.0000152646,0.00001431622,0.000004285868],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007182779,"about_ca_system_score_gemma":0.00006974141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006950532,"about_ca_topic_score_gemma":0.00008866382,"domain_scores_codex":[0.9993063,0.00001963177,0.0002048408,0.0002393321,0.0001031833,0.0001267017],"domain_scores_gemma":[0.9996431,0.00005326327,0.00006659053,0.0001217191,0.00001906527,0.00009621638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002033591,0.001515905,0.9888982,0.000194378,0.00004928264,0.0002340645,0.0004023684,0.00001274195,0.0007038109,0.00006975409,0.00003292255,0.007683263],"study_design_scores_gemma":[0.01351638,0.001280723,0.9668068,0.0001505098,0.0001653982,0.00001622319,0.0001371547,0.00002203894,0.01060316,0.00009825257,0.007107934,0.00009548516],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9528104,0.04502978,0.000003279312,0.0006622961,0.00002061744,0.0002544405,0.00003038552,0.00001647336,0.001172339],"genre_scores_gemma":[0.9916096,0.005336776,0.002628522,0.0001583786,0.00004145527,0.00005369358,0.000008235371,0.000009488689,0.0001538295],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03969301,"threshold_uncertainty_score":0.3758848,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2883847557","doi":"10.1182/bloodadvances.2018017418","title":"Significant gynecological bleeding in women with low von Willebrand factor levels","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Science Foundation Ireland","keywords":"Von Willebrand factor; Medicine; Pregnancy; Plasma levels; Von Willebrand disease; Obstetrics; Gynecology; Internal medicine; Endocrinology; Platelet; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01389942350459045,"gpt":0.2620923926778076,"spread":0.2481929691732171,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000506485,0.00014493,0.0003172276,0.00006453897,0.00005824465,0.00001363995,0.00005397641,0.00005431617,0.0002842834],"category_scores_gemma":[0.00004442381,0.00008969822,0.00001942691,0.0001646349,0.000116064,0.000145284,0.00001552304,0.0000889328,0.0000292634],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003961034,"about_ca_system_score_gemma":0.00004251224,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007016124,"about_ca_topic_score_gemma":0.00004201543,"domain_scores_codex":[0.9990738,0.00001323058,0.0001477354,0.0002643761,0.0001569161,0.0003439148],"domain_scores_gemma":[0.9996329,0.00006461059,0.00005122385,0.0001066108,0.00003522107,0.0001094155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002509588,0.003093432,0.8658554,0.000179143,0.0004439379,0.002829101,0.002350405,0.00001174544,0.0243082,0.00009803274,0.00005998042,0.09826106],"study_design_scores_gemma":[0.01707137,0.008109623,0.9256356,0.0004046297,0.0001163721,0.0001490039,0.001311716,0.00003343797,0.03669212,0.0007259415,0.009275166,0.000475052],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960997,0.0004284179,0.00001702303,0.0001521277,0.00005937914,0.0002788089,0.00001312405,0.00004114578,0.002910295],"genre_scores_gemma":[0.9985936,0.0001334898,0.0006857024,0.0002090643,0.00007069667,0.00004281916,0.000003144961,0.00001221635,0.0002492564],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09778601,"threshold_uncertainty_score":0.3657787,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2811286257","doi":"10.1182/bloodadvances.2018016584","title":"Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"National Cancer Institute; National Institutes of Health; Enzon Pharmaceuticals","keywords":"Medicine; Lymphoblastic Leukemia; Protocol (science); Oncology; Internal medicine; Leukemia; Pediatrics; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02030835921070442,"gpt":0.3242821859915467,"spread":0.3039738267808423,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006920882,0.0003212035,0.0006236138,0.0003636974,0.0001060374,0.00002407988,0.0003383107,0.0002346828,0.0000601867],"category_scores_gemma":[0.001933114,0.0002653303,0.00009271996,0.0007308907,0.0005830006,0.000308982,0.0001401629,0.0004183193,0.0001142546],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00058481,"about_ca_system_score_gemma":0.001452541,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002688277,"about_ca_topic_score_gemma":0.0001993853,"domain_scores_codex":[0.9965354,0.0001719152,0.001100664,0.0007459521,0.0007710264,0.000675034],"domain_scores_gemma":[0.9973969,0.0005429458,0.000662576,0.0007597219,0.0004033459,0.0002344673],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.05900938,0.01744349,0.2963807,0.003858866,0.004619782,0.002412884,0.008996296,0.000566454,0.2784714,0.002568537,0.02471803,0.3009542],"study_design_scores_gemma":[0.1812924,0.01367415,0.448524,0.003396978,0.00184969,0.001332849,0.001005629,0.009908799,0.1871815,0.001023444,0.1491912,0.001619367],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9252143,0.0002701053,0.000477864,0.0007821915,0.0003789305,0.0425658,0.00038558,0.0003524978,0.02957276],"genre_scores_gemma":[0.9759888,0.0001508907,0.006942277,0.0002320341,0.0004953583,0.01491486,0.0001061142,0.00007317094,0.001096479],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2993349,"threshold_uncertainty_score":0.9999799,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2896704395","doi":"10.1182/bloodadvances.2018023572","title":"High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; Spinal Cord Injury BC","funders":"Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre","keywords":"BCL6; Breakpoint; Biology; Gene rearrangement; Lymphoma; Fluorescence in situ hybridization; Gene duplication; Chromosomal translocation; Locus (genetics); Cancer research; Gene; Diffuse large B-cell lymphoma; Comparative genomic hybridization; Genetics; Molecular biology; B cell; Antibody; Chromosome; Immunology; Germinal center","retraction":null,"screen_n_in":null,"score":{"opus":0.00887678908744598,"gpt":0.2538285722647307,"spread":0.2449517831772847,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004552912,0.0001113662,0.0002405285,0.00007864539,0.00003099492,0.000003761086,0.0000323464,0.00004133232,0.00002423712],"category_scores_gemma":[0.0000118161,0.00007194135,0.00001938641,0.0001122775,0.0001891632,0.00004915376,0.00002189166,0.00001954705,0.00000432094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001772989,"about_ca_system_score_gemma":0.00002830113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002104388,"about_ca_topic_score_gemma":0.0003304918,"domain_scores_codex":[0.9993244,0.00002379566,0.0001464112,0.0002171385,0.0001235578,0.0001646869],"domain_scores_gemma":[0.9996548,0.00002953618,0.00006976649,0.0001526529,0.00004205879,0.00005114103],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006148758,0.001428415,0.8872322,0.00008602141,0.0001586385,0.0001571843,0.0002743702,0.00001541616,0.005347577,0.0003609683,0.00006548336,0.1042589],"study_design_scores_gemma":[0.01135884,0.002000851,0.9165694,0.0001896159,0.0001957765,0.0001900003,0.0000731055,0.000007686991,0.06262846,0.000274418,0.006404996,0.0001068614],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926116,0.006110012,0.00002269599,0.000339403,0.00005120348,0.0002231358,0.000009544501,0.00001512484,0.0006172372],"genre_scores_gemma":[0.9941363,0.000763099,0.004724839,0.0001267572,0.00009385394,0.00004446999,0.00001330808,0.0000093065,0.00008808629],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.104152,"threshold_uncertainty_score":0.2933683,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2889602315","doi":"10.1182/bloodadvances.2018022608","title":"Single-cell heterogeneity in Sézary syndrome","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Kom op tegen Kanker; Rigshospitalet; Danmarks Frie Forskningsfond; H. Lundbeck A/S; Lundbeckfonden; Novo Nordisk; Gentofte Hospital; Novo Nordisk Fonden; Kræftens Bekæmpelse","keywords":"Romidepsin; Cancer research; Population; Biology; Cell; Flow cytometry; Lymphoma; Antigen; Immunology; Histone deacetylase; Medicine; Histone; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.0249808962531721,"gpt":0.3120613421799412,"spread":0.2870804459267691,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001170791,0.0001432392,0.0002660457,0.0001516928,0.00006496406,0.00001703546,0.0001163589,0.00006064583,0.0002221542],"category_scores_gemma":[0.0001192699,0.0001264233,0.0000582135,0.0003198508,0.0002287508,0.0001264431,0.00006128657,0.0001292273,0.0001971882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005042986,"about_ca_system_score_gemma":0.0000869283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002670635,"about_ca_topic_score_gemma":0.0003347767,"domain_scores_codex":[0.9987053,0.0000526631,0.0002097668,0.0003418223,0.0003134889,0.0003769067],"domain_scores_gemma":[0.9993919,0.00006241501,0.00003972062,0.0002762363,0.0001080096,0.0001217425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004382178,0.002777229,0.8463147,0.0002610416,0.00006197992,0.002008668,0.0003754197,0.0000051005,0.1366323,0.00003279607,0.0001531869,0.01093945],"study_design_scores_gemma":[0.01010645,0.008385832,0.09078041,0.0004103335,0.0001159101,0.0107809,0.0006139051,0.0002437773,0.835993,0.0009295786,0.04089024,0.0007496692],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9798917,0.004381183,0.00002493042,0.0002409799,0.00008127659,0.0003609922,0.000006461462,0.00005368765,0.01495884],"genre_scores_gemma":[0.997368,0.0001820174,0.0009914965,0.0003004111,0.0001008155,0.00002609135,0.000009561876,0.00002373248,0.0009978121],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7555342,"threshold_uncertainty_score":0.5155394,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2992108607","doi":"10.1182/bloodadvances.2019000791","title":"The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"MAGIC (telescope); Biomarker; Algorithm; Medicine; Disease; Internal medicine; Computer science; Biology; Physics","retraction":null,"screen_n_in":null,"score":{"opus":0.02049118854891974,"gpt":0.3005570516442381,"spread":0.2800658630953183,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002236537,0.0001484893,0.000304617,0.00004920399,0.0000330709,0.00000581927,0.00008231773,0.00003754525,0.00009145167],"category_scores_gemma":[0.00003850492,0.0000900654,0.000137945,0.0002111147,0.0001497968,0.00007629835,0.000009960123,0.00003045302,0.00002352556],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000386118,"about_ca_system_score_gemma":0.0001632454,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001616513,"about_ca_topic_score_gemma":0.000002599747,"domain_scores_codex":[0.9988199,0.0001306781,0.0003558943,0.000250424,0.0002687414,0.0001743257],"domain_scores_gemma":[0.9986371,0.0004938366,0.0001590067,0.000485654,0.0001217333,0.0001026789],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1258268,0.00678297,0.3020081,0.003230319,0.005380119,0.0002958091,0.00524407,0.00001400342,0.5038733,0.0003912317,0.0001061229,0.04684707],"study_design_scores_gemma":[0.02561692,0.006252725,0.2712677,0.0006324275,0.004768108,0.00005954353,0.0005899118,0.0005806654,0.677088,0.0006113964,0.01214228,0.0003903877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957271,0.001694926,0.0001020735,0.0005484052,0.0001677091,0.001115546,0.0002833978,0.00002752046,0.0003332798],"genre_scores_gemma":[0.9931705,0.001484023,0.004130499,0.00002416586,0.00001709253,0.00004937538,0.0000509624,0.00001971008,0.001053693],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1732146,"threshold_uncertainty_score":0.3672761,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3040264829","doi":"10.1182/bloodadvances.2020001758","title":"Platelet-derived extracellular vesicles infiltrate and modify the bone marrow during inflammation","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research; Advanced Medical Research Foundation; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Brigham and Women's Hospital; Boston Children's Hospital; Breast Cancer Research Foundation","keywords":"Bone marrow; Inflammation; Haematopoiesis; Flow cytometry; Platelet; Myeloid; Megakaryocyte; Cell biology; Immunology; In vivo; Immunophenotyping; Chemistry; Biology; Pathology; Stem cell; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.008159017298855882,"gpt":0.2146921939964882,"spread":0.2065331766976324,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000881294,0.0001690918,0.0001240383,0.00001469973,0.0001603801,0.0000537644,0.0001751222,0.00007720159,0.00001206004],"category_scores_gemma":[0.0001086944,0.0001391941,0.00005392942,0.00007337734,0.0001443904,0.00002306011,0.0001162381,0.0001044477,0.000008429717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000002772235,"about_ca_system_score_gemma":0.00002324533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001518595,"about_ca_topic_score_gemma":0.000005664517,"domain_scores_codex":[0.9990308,0.00006391133,0.0002230404,0.0003380562,0.0001307804,0.000213377],"domain_scores_gemma":[0.9994639,0.00001590647,0.0001183771,0.0002423562,0.00003286494,0.0001266293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009485649,0.0000206873,0.00116773,0.00007587484,0.00003674198,0.00003297038,0.0001344823,0.0003597059,0.9941702,0.00008596011,0.0000210263,0.003799797],"study_design_scores_gemma":[0.0007968265,0.0000864145,0.002686433,0.0000131603,0.00003654518,0.00003103983,0.000168335,0.0001993232,0.9865907,0.000195463,0.008999079,0.0001966448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9651156,0.03340333,0.0003336484,0.000708792,0.00003800057,0.0002204537,0.00001282525,0.0000335799,0.000133763],"genre_scores_gemma":[0.9969945,0.001513094,0.000815672,0.0001369382,0.0003702245,0.00002519288,0.00003672786,0.00002528265,0.0000823762],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03189023,"threshold_uncertainty_score":0.567617,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3176618462","doi":"10.1182/bloodadvances.2021004629","title":"Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients","year":2021,"lang":"en","type":"review","venue":"Blood Advances","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":106,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Seroconversion; Confidence interval; Influenza vaccine; CD20; Immunogenicity; Immunology; Gastroenterology; Vaccination; Antigen; Antibody; Lymphoma","retraction":null,"screen_n_in":null,"score":{"opus":0.03856182996323942,"gpt":0.3287690543417925,"spread":0.2902072243785531,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001490319,0.0007375766,0.01493968,0.0005764965,0.0001646855,0.00002604647,0.0005049556,0.0003551906,0.0004932543],"category_scores_gemma":[0.0008231297,0.0004569637,0.005087095,0.001348325,0.00008112549,0.0001757667,0.0001255827,0.0003418454,0.00002114538],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001727361,"about_ca_system_score_gemma":0.0001479414,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008489834,"about_ca_topic_score_gemma":0.00000226776,"domain_scores_codex":[0.9921116,0.004824662,0.001941725,0.0006451219,0.0001071163,0.0003698048],"domain_scores_gemma":[0.9950108,0.002093828,0.001637175,0.001070835,0.0001653125,0.00002203506],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00009860257,0.0003914393,0.000008611027,0.3150775,0.6765889,0.00001188998,0.0000789273,1.505773e-7,0.00008899565,0.000009450456,0.00003700407,0.007608518],"study_design_scores_gemma":[0.0005451108,0.0001794985,0.0000097846,0.02971818,0.6930827,0.00002677671,0.00001823547,7.36999e-9,0.0001174433,8.300607e-7,0.2759584,0.0003430475],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002344189,0.9972008,0.00000262969,0.00003066243,0.000162977,0.002064679,0.0002574539,0.00003437185,0.00001200391],"genre_scores_gemma":[0.0001013736,0.9971747,0.00003538985,0.000208466,0.000003567949,0.0004152373,0.0003786809,0.00005294616,0.001629612],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2853594,"threshold_uncertainty_score":0.9997882,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3093553460","doi":"10.1182/bloodadvances.2020001742","title":"Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"Universität Wien; Medizinische Universität Wien; Austrian Science Fund; Celgene","keywords":"CD38; CD34; Stem cell; Myeloid leukemia; Bone marrow; Molecular biology; Antigen; Biology; Leukemia; CD33; Myeloid; Cancer research; Immunology; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01645825524004815,"gpt":0.2756455365045918,"spread":0.2591872812645436,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000200957,0.0001623466,0.0003807179,0.0001394999,0.00003233326,0.00001649207,0.0000662118,0.00009582445,0.000009830261],"category_scores_gemma":[0.0001293566,0.0001318025,0.00001888717,0.0002599159,0.0001314391,0.0002583003,0.0001149468,0.0002315626,0.000001382613],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002475982,"about_ca_system_score_gemma":0.00009135661,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002860165,"about_ca_topic_score_gemma":0.00001873719,"domain_scores_codex":[0.9986632,0.00008267343,0.000364066,0.0003910749,0.00026153,0.0002374177],"domain_scores_gemma":[0.9994242,0.0001190488,0.0001028665,0.0001197604,0.00007217396,0.0001620202],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006436544,0.0001820688,0.365413,0.001424504,0.00002278159,0.00009080381,0.001812845,0.00002422023,0.6090035,0.00002133008,0.0001846121,0.0211767],"study_design_scores_gemma":[0.006569199,0.000817328,0.02716874,0.0006438061,0.00004819058,0.00003376606,0.002297383,0.003109349,0.9547107,0.00008825849,0.004276351,0.0002369057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875804,0.01036521,0.0000710361,0.0009610378,0.00002560691,0.0008723004,0.00002835399,0.00002336117,0.000072681],"genre_scores_gemma":[0.9874683,0.002280211,0.009805973,0.0001212041,0.0001293185,0.00006322184,0.000018674,0.00002197543,0.00009110164],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3457072,"threshold_uncertainty_score":0.5374749,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2989047686","doi":"10.1182/bloodadvances.2019000449","title":"More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Health and Medical Research Council; National Institutes of Health","keywords":"Medicine; Oncology; Negativity effect; Internal medicine; Peri; Psychology; Developmental psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.008444506848344384,"gpt":0.2535488958911792,"spread":0.2451043890428348,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003188767,0.0002735236,0.0004794407,0.0001422952,0.00009007965,0.0000525212,0.00008457568,0.0001090937,0.00001485739],"category_scores_gemma":[0.0002011801,0.0002199168,0.0000999076,0.0001513643,0.00002673836,0.0003211104,0.00008366835,0.0001914306,0.00002283911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006364529,"about_ca_system_score_gemma":0.0001135093,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001180394,"about_ca_topic_score_gemma":0.0004729968,"domain_scores_codex":[0.9982275,0.0001055208,0.0003427108,0.0005528338,0.0003696424,0.0004017678],"domain_scores_gemma":[0.9990977,0.0001988718,0.0001727114,0.0002808247,0.00008435066,0.0001655165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006634068,0.0005838828,0.9842001,0.00009653307,0.0001389866,0.00005971616,0.0007202416,0.002446993,0.000109424,0.00002409532,0.000006003656,0.01095063],"study_design_scores_gemma":[0.008420687,0.001118063,0.9846732,0.0001314791,0.001154088,0.00007427793,0.0001819879,0.002875731,0.0007007951,0.0001353704,0.0002366593,0.0002976578],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9723142,0.02601268,0.00001606246,0.0001257699,0.0001936625,0.0006990025,0.0001056628,0.00006540583,0.000467505],"genre_scores_gemma":[0.975781,0.02173388,0.0020293,0.00008767237,0.0001821025,0.00007526454,0.0000412092,0.00003332701,0.00003619722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01065297,"threshold_uncertainty_score":0.8967948,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2981626013","doi":"10.1182/bloodadvances.2019000593","title":"Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Hematopoietic cell; CAR T-cell therapy; CD19; Medicine; Cell therapy; Hematopoietic stem cell transplantation; Genetic enhancement; Haematopoiesis; Oncology; Toxicity; Chimeric antigen receptor; Internal medicine; Immunology; Transplantation; Stem cell; T cell; Peripheral blood; Biology; Gene; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.006991509777375879,"gpt":0.2490289107636882,"spread":0.2420374009863124,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002231418,0.0002351719,0.0005463875,0.0001648086,0.00001743574,0.000005862162,0.0001878893,0.0001173305,0.003176443],"category_scores_gemma":[0.000005558919,0.0001885405,0.0001682532,0.0002796386,0.00008264815,0.00009520979,0.00002047126,0.0002610808,0.000088788],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002938091,"about_ca_system_score_gemma":0.0001052106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004814005,"about_ca_topic_score_gemma":0.00005651113,"domain_scores_codex":[0.9981361,0.0000884238,0.0004468148,0.0004208044,0.0004667198,0.0004411628],"domain_scores_gemma":[0.9991042,0.0001197016,0.00009068576,0.0004811794,0.00007857881,0.0001256715],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006632582,0.001146171,0.2328794,0.001069709,0.00006413672,0.0001451469,0.002241048,0.00004186276,0.7519373,0.000006822416,0.000008697965,0.003827079],"study_design_scores_gemma":[0.01651157,0.001468512,0.0358867,0.0005802855,0.00005170851,0.00004119122,0.0004477186,0.00002565351,0.9333782,0.00005555509,0.01123376,0.0003191376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.964303,0.02958512,0.000007111423,0.0001009704,0.0001153008,0.001040998,0.00003885231,0.0000306645,0.004778053],"genre_scores_gemma":[0.9841152,0.01215174,0.0003855067,0.0001418744,0.00005867127,0.00005901704,0.00003070898,0.00004565395,0.003011606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1969927,"threshold_uncertainty_score":0.9977348,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2936913202","doi":"10.1182/bloodadvances.2018030577","title":"Targeting CD47 in Sézary syndrome with SIRPαFc","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Trillium Therapeutics (Canada)","funders":"National Cancer Institute","keywords":"CD47; Phagocytosis; Lymphoma; Decoy; Medicine; Cutaneous T-cell lymphoma; Cancer research; Immunology; Receptor; Internal medicine; Mycosis fungoides","retraction":null,"screen_n_in":null,"score":{"opus":0.009672638446286328,"gpt":0.2801466938646356,"spread":0.2704740554183492,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002082273,0.0001249973,0.0002883607,0.0001257017,0.00002474342,0.00001344261,0.0001060902,0.00004492736,0.00180013],"category_scores_gemma":[0.00003661456,0.00009355202,0.00003648358,0.0003052171,0.00005239189,0.0001772902,0.00003641786,0.0002571596,0.0001579149],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002942664,"about_ca_system_score_gemma":0.00007496431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002800582,"about_ca_topic_score_gemma":0.00002296256,"domain_scores_codex":[0.9988027,0.00003261443,0.0001679788,0.0002904294,0.0003606237,0.000345625],"domain_scores_gemma":[0.9994702,0.00009815252,0.00004281261,0.0002591063,0.00004252974,0.00008717263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007963908,0.0005137779,0.7847587,0.0004666513,0.0001256777,0.002489322,0.0003303987,0.000275651,0.1970533,0.00008257122,0.00007007222,0.01303751],"study_design_scores_gemma":[0.04285132,0.01292728,0.4177577,0.003633959,0.0002955827,0.007354936,0.0043182,0.0008918782,0.1159979,0.00104379,0.39086,0.00206738],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9794697,0.004311919,0.000006870401,0.0002746273,0.00007405648,0.0005062772,0.000002155109,0.000051731,0.01530272],"genre_scores_gemma":[0.9867179,0.0004171857,0.00138655,0.0001505787,0.00007747352,0.00002653546,0.00001165631,0.00003207212,0.01118007],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3907899,"threshold_uncertainty_score":0.9991124,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}